Literature DB >> 6478891

Long-term follow-up of left ventricular thrombus after acute myocardial infarction. A two-dimensional echocardiographic study in 96 patients.

C A Visser, G Kan, R S Meltzer, K I Lie, D Durrer.   

Abstract

To determine the incidence, natural history, and relation to anticoagulant therapy of left ventricular thrombus (LVT) following acute myocardial infarction (MI), we performed two-dimensional echocardiography in 96 consecutive patients with isolated MI during the acute episode and after four and 12 months. Only patients with anterior MI received oral anticoagulant therapy on admission and throughout the study period. The LVT was identified in 21/65 patients with anterior and in 1/31 patients with inferior MI. The large majority of LVT cases were seen for the first time during the acute phase of MI. LVT was associated with a significantly higher peak value of CK-MB (118 +/- 24 vs 76 +/- 35, p less than 0.001) and Killip class (2.5 +/- 0.8 vs. 1.5 +/- 0.7, p less than 0.002). Patients with anterior MI and LVT more frequently had segmental dyskinesia during acute MI than patients without LVT (86 percent vs 18 percent, p less than 0.001). In four patients LVT resolved during the study period. Discontinuation of anticoagulant therapy in four patients with an aneurysm led to LVT formation in three. Two patients suffered a clinically recognized embolic event; one never had LVT demonstrated by echocardiography. Thus, LVT usually develops in the early days following large anterior MI, complicated by pump failure and segmental dyskinesia, even when patients receive oral anticoagulant therapy. Surprisingly, the incidence of embolic events was low (1/22) in our LVT patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478891     DOI: 10.1378/chest.86.4.532

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack : part 2].

Authors:  P D Schellinger; P Ringleb; W Hacke
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

Review 2.  Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.

Authors:  M Verstraete
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 3.  Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.

Authors:  J R Stratton
Journal:  West J Med       Date:  1989-08

4.  Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care.

Authors:  M K Kapral; F L Silver
Journal:  CMAJ       Date:  1999-10-19       Impact factor: 8.262

5.  Thrombi of different pathologies: implications for diagnosis and treatment.

Authors:  Carlos G Santos-Gallego; Jeremías Bayón; Juan José Badimón
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-06

6.  Long term follow up of patients with anterior myocardial infarction complicated by left ventricular thrombus in the thrombolytic era.

Authors:  T Mooe; D Teien; K Karp; P Eriksson
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

7.  Left atrial myxoma and concomitant atherosclerotic coronary artery disease.

Authors:  Hasan Kocaturk; Adem Karaman; Ednan Bayram; Mehmet Cengiz Çolak; Volkan Yurtman
Journal:  Eurasian J Med       Date:  2009-12

8.  Risk factors for development of left ventricular thrombus after first acute anterior myocardial infarction-association with anticardiolipin antibodies.

Authors:  Ertuğrul Okuyan; Barış Okcun; Mustafa H Dinçkal; Haşim Mutlu
Journal:  Thromb J       Date:  2010-09-19

9.  Antithrombotic therapy in cardiac embolism.

Authors:  Alvaro Cervera; Angel Chamorro
Journal:  Curr Cardiol Rev       Date:  2010-08

10.  Successful medical management of a left ventricular thrombus and aneurysm following failed thrombolysis in myocardial infarction.

Authors:  Adebayo T Oyedeji; Christopher Lee; Olukolade O Owojori; Olabanji J Ajegbomogun; Adeseye A Akintunde
Journal:  Clin Med Insights Cardiol       Date:  2013-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.